{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05287451",
            "orgStudyIdInfo": {
                "id": "2021-1089"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2022-01291",
                    "type": "OTHER",
                    "domain": "NCI-CTRP Clinical Registry"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study",
            "officialTitle": "Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "risk-reducing-salpingectomy-with-delayed-oophorectomy-as-an-alternative-to-risk-reducing-salpingo-oophorectomy-in-high-risk-women-to-assess-the-safety-of-prevention-us-cohort-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-05-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-12-26",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12-26",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-02-07",
            "studyFirstSubmitQcDate": "2022-03-10",
            "studyFirstPostDateStruct": {
                "date": "2022-03-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a prospective preference study that will evaluate non-inferiority of the innovative treatment (RRS with delayed RRO) as compared to the standard treatment (RRSO) with respect to high grade serous (ovarian) cancer incidence",
            "detailedDescription": "The aim of the project is to evaluate RRS with delayed RRO as an alternative for RRSO in BRCA1/2 gene germline mutation carriers with respect to ovarian cancer incidence. We hypothesize that postponement of oophorectomy and consequent menopause to the age of 40-45 (BRCA1) or 45-50 (BRCA2) compared to current standard RRSO at age 35-40 (BRCA1) or 40-45 (BRCA2) will not lead to a significant increase in ovarian cancer risk.\n\nPRIMARY OBJECTIVE:\n\nTo evaluate non-inferiority of the innovative treatment (RRS with delayed RRO) as compared to the standard treatment (RRSO) with respect to high grade serous (ovarian) cancer incidence in BRCA1/2 gene germline mutation carriers.\n\nSECONDARY OBJECTIVE:\n\nIncidence of (pre)malignant findings in tubes/ovaries, perioperative morbidity and mortality, incidence of non-ovarian pelvic cancer, breast cancer, prophylactic breast surgery and uptake of risk reducing oophorectomy.\n\nEXPLORATORY OBJECTIVE:\n\nEstimate high grade serous (ovarian) cancer incidence for innovative and standard treatments in BRIP1, RAD51C, and RAD51D gene germline mutation carriers"
        },
        "conditionsModule": {
            "conditions": [
                "Ovarian Cancer",
                "Fallopian Tube Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Risk-Reducing Salpingectomy-RRS",
                    "type": "OTHER",
                    "description": "Can help to lower the risk of ovarian cancer with a delayed removal of 1.",
                    "interventionNames": [
                        "Other: RIsk-Reducing Salpingectomy (RRS)"
                    ]
                },
                {
                    "label": "Risk-Reducing Oophorectomy-RRO",
                    "type": "OTHER",
                    "description": "Can help to lower the risk of ovarian cancer removing both fallopian tubes.",
                    "interventionNames": [
                        "Other: Risk-Reducing Oophorectomy-RRO"
                    ]
                },
                {
                    "label": "Risk-Reducing Salpingo-Oophorectomy-RRSO",
                    "type": "OTHER",
                    "description": "Can help to lower the risk of ovarian cancer as well as the standard-of-care risk-reducing procedure involving the removal of the fallopian tubes and ovaries (risk-reducing salpingo-oophorectomy-RRSO)",
                    "interventionNames": [
                        "Other: Risk-Reducing Salpingo-Oophorectomy-RRSO"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "RIsk-Reducing Salpingectomy (RRS)",
                    "description": "complete questionnaires, standard-of-care laparoscopy to check the abdominal area before the assigned procedure",
                    "armGroupLabels": [
                        "Risk-Reducing Salpingectomy-RRS"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Risk-Reducing Oophorectomy-RRO",
                    "description": "complete questionnaires, standard-of-care laparoscopy to check the abdominal area before the assigned procedure",
                    "armGroupLabels": [
                        "Risk-Reducing Oophorectomy-RRO"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Risk-Reducing Salpingo-Oophorectomy-RRSO",
                    "description": "complete questionnaires, standard-of-care laparoscopy to check the abdominal area before the assigned procedure",
                    "armGroupLabels": [
                        "Risk-Reducing Salpingo-Oophorectomy-RRSO"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "To evaluate the non-inferiority of the innovative treatment (RRS with delayed RRO) as compared to the standard treatment (RRSO) with respect to high grade serous (ovarian) cancer incidence in BRCA1/2 gene germline mutation carriers.",
                    "timeFrame": "through study completion, an average of 1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Premenopausal women with a documented deleterious mutation in BRCA1, BRCA2, BRIP1, RAD51C and/or RAD51D gene germline mutation.\n2. Age 25-40 years for BRCA1 mutation carriers, 25-45 years for BRCA2 and 30-50 years for BRIP1, RAD51C, RAD51D\n3. Childbearing completed or no longer requires fallopian tubes\n4. Presence of at least one fallopian tube\n5. Participants may have a personal history of non-ovarian malignancy.\n6. Informed consent must be obtained and documented.\n\nExclusion Criteria:\n\n1. Postmenopausal status (natural menopause or due to (cancer) treatment)\n2. Wish for second stage RRO within two years after RRS (if clear at enrollment)\n3. Legally incapable\n4. Prior bilateral salpingectomy\n5. A personal history of ovarian, fallopian tube or peritoneal cancer\n6. Current clinicals signs, diagnosis or treatment for malignant disease",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "genderBased": true,
            "genderDescription": "Female",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Karen Lu, MD",
                    "role": "CONTACT",
                    "phone": "(713) 745-8902",
                    "email": "khlu@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Karen Lu, MD",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Harvard Cancer Center",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Colleen Feltmate, MD",
                            "role": "CONTACT",
                            "phone": "617-732-8843",
                            "email": "cfeltmate@bwh.harvard.edu"
                        },
                        {
                            "name": "Colleen Feltmate, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Washington University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63130",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Andrea Hagemann, MD",
                            "role": "CONTACT",
                            "phone": "314-362-3181",
                            "email": "hagemanna@wustl.edu"
                        },
                        {
                            "name": "Andrea Hagemann, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "M D Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Karen Lu, MD",
                            "role": "CONTACT",
                            "phone": "713-745-8902",
                            "email": "khlu@mdanderson.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Fred Hutch/University of Washington/Seattle Children's Cancer Consortium",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98195",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Barbara Norquist, MD",
                            "role": "CONTACT",
                            "phone": "206-598-8300",
                            "email": "bnorquis@uw.edu"
                        },
                        {
                            "name": "Barbara Norquist, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "M D Anderson Cancer Center",
                    "url": "http://www.mdanderson.org"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005185",
                    "term": "Fallopian Tube Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000000291",
                    "term": "Adnexal Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000005184",
                    "term": "Fallopian Tube Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12974",
                    "name": "Ovarian Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M1704",
                    "name": "Carcinoma, Ovarian Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M8328",
                    "name": "Fallopian Tube Neoplasms",
                    "asFound": "Fallopian Tube Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3643",
                    "name": "Adnexal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8327",
                    "name": "Fallopian Tube Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4352",
                    "name": "Ovarian Cancer",
                    "asFound": "Ovarian Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4354",
                    "name": "Ovarian Epithelial Cancer",
                    "relevance": "LOW"
                },
                {
                    "id": "T2189",
                    "name": "Fallopian Tube Cancer",
                    "asFound": "Fallopian Tube Cancer",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}